跳至主要内容
临床试验/IRCT20220101053582N2
IRCT20220101053582N2尚未招募Unknown

Investigating the effect of oral magnesium supplementation on cognitive function, fatigue, depression, anxiety and serum levels of magnesium, BDNF, IL-6 and Superoxide Dismutase II in relapsing-remitting multiple sclerosis patients

Tehran University of Medical Sciences0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • The individual's willingness to participate in the study
  • Definite patients with relapsing-remitting MS based on the 2017 McDonald diagnostic criteria (20) who are on file at Sinai Hospital
  • Age range 18-55 years
  • EDSS less than 5.5
  • Education above diploma
  • More than one month has passed since the last corticosteroid injection (pulse therapy)
  • More than one month has passed since the last relapse of the disease

排除标准

  • Suffering from another neurological disease other than MS
  • Pregnancy or breastfeeding
  • Suffering from chronic gastrointestinal, liver, kidney, heart, respiratory and cancer diseases
  • Having a diet for any reason
  • Suffering from severe psychological disorders such as major depression
  • History of allergy to Magnesium

研究者

相似试验